Literature DB >> 30231786

Effect of exercise on type 2 diabetes-associated cognitive impairment in rats.

Bina Kumari Mehta1, Kaushal Kumar Singh2, Sugato Banerjee1.   

Abstract

OBJECTIVES: Type 2 diabetes (T2D)-associated cognitive impairment is highly prevalent especially among the geriatric population. Here, we investigate the role of exercise in T2D-associated cognitive decline in rats.
METHODS: T2D was induced using high-fat diet (15 days) followed by low-dose STZ (25mg/kg). The T2D animals were subjected to aerobic exercise on running wheel for 6 weeks. Effect of aerobic exercise on cognitive performance of T2D animals was measured using step-down and transfer latency tests. This was followed by the measurement of reduced glutathione levels in hippocampal homogenates. We also measured hippocampal AchE activity and levels of neuroinflammatory markers such as IL-1 β, TNF-α and MCP-1. Morphology and density of hippocampal neurons were also determined by histopathological studies.
RESULTS: Exercise led to the following changes in T2D animals. It led to decrease in fasting blood glucose level (<250 mg/kg) and HbA1c (8.5 ± 0.23) compared to diabetic (11.73 ± 0.14) animals and improved insulin resistance. There was an increase in step-down latency (p < 0.001) and a decrease in transfer latency (p < 0.01) suggesting improved cognitive function. A significant increase in GSH levels (1.828 ± 0.024) compared to diabetic group (1.52 ± 0.03; p < 0.001) and decrease in AchE activity (1.4 ± 0.05) compared to diabetic group (1.65 ± 0.03; p < 0.05) were also observed. It reduced the levels of neuroinflammatory markers such as IL-1β, TNF-α and MCP-1 (p < 0.01). Hippocampal sections showed higher CA1 and CA3 neuronal density (p < 0.001) than T2D group.
CONCLUSION: We may conclude that aerobic exercise could partially reverse diabetes-associated cognitive decline by reducing oxidative stress and inflammatory milieu in T2D animal brain.

Entities:  

Keywords:  Cognition; diabetes; exercise; memory; neuroinflammation

Mesh:

Year:  2018        PMID: 30231786     DOI: 10.1080/00207454.2018.1526795

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  6 in total

Review 1.  Obesity-related cognitive impairment: The role of endothelial dysfunction.

Authors:  Joy Jones Buie; Luke S Watson; Crystal J Smith; Catrina Sims-Robinson
Journal:  Neurobiol Dis       Date:  2019-08-24       Impact factor: 5.996

2.  Swimming training and Plantago psyllium ameliorate cognitive impairment and glucose tolerance in streptozotocin-nicotinamide-induced type 2 diabetic rats.

Authors:  Hesam Parsa; Zahra Moradi-Khaligh; Sara Rajabi; Kamal Ranjbar; Alireza Komaki
Journal:  J Physiol Sci       Date:  2021-11-27       Impact factor: 2.257

3.  Peripheral and cognitive benefits of physical exercise in a mouse model of midlife metabolic syndrome.

Authors:  Farida El Gaamouch; Hsiao-Yun Lin; Qian Wang; Wei Zhao; Jiangping Pan; Kalena Liu; Jean Wong; Clark Wu; Chongzhen Yuan; Haoxiang Cheng; Weiping Qin; Ke Hao; Bin Zhang; Jun Wang
Journal:  Sci Rep       Date:  2022-02-28       Impact factor: 4.996

Review 4.  The Role of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) in Diabetes-Related Neurodegenerative Diseases.

Authors:  Dihe Cheng; Shuo Yang; Xue Zhao; Guixia Wang
Journal:  Drug Des Devel Ther       Date:  2022-03-14       Impact factor: 4.162

5.  Potential of prevention strategies for the modifiable risk factor type 2 diabetes with relation to the future number of dementia patients in Germany- a multi-state projection through 2040.

Authors:  Anne Fink; Achim Doerre; Ilja Demuth; Gabriele Doblhammer
Journal:  BMC Neurol       Date:  2022-04-26       Impact factor: 2.903

6.  Modulation of High-Fat Diet-Induced Brain Oxidative Stress by Ferulate-Rich Germinated Brown Rice Ethyl Acetate Extract.

Authors:  Nur Hanisah Azmi; Norsharina Ismail; Mustapha Umar Imam; Der Jiun Ooi; Siti Nur Hazwani Oslan
Journal:  Molecules       Date:  2022-07-31       Impact factor: 4.927

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.